SEC CIK 1590794
Vergis Janet S.
Reported ownership across 4 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| TEVAview stock → | 73,697 | 2025-06-06 |
| XRAYview stock → | 67,324 | 2026-06-03 |
| CHDview stock → | 21,188 | 2026-07-01 |
| AMRXview stock → | 18,257 | 2019-05-08 |
Position History — CHD
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CHD
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-07-01 | Grant / award | 736 | $96.88 | 21,188 |
| 2026-05-04 | Grant / award (derivative) | 3,060 | $0.00 | 3,060 |
| 2026-05-04 | Grant / award | 920 | $0.00 | 920 |
| 2026-02-04 | Option exercise (derivative) | 12,960 | $0.00 | 0 |
| 2026-02-04 | Open-market sale | 12,960 | $101.00 | 17,102 |
| 2026-02-04 | Option exercise | 12,960 | $49.62 | 30,062 |
| 2025-06-30 | Grant / award | 729 | $96.11 | 17,102 |
| 2025-05-02 | Grant / award (derivative) | 2,890 | $0.00 | 2,890 |
| 2025-05-02 | Grant / award | 860 | $0.00 | 860 |
| 2024-06-30 | Grant / award | 676 | $103.68 | 16,373 |
| 2024-05-03 | Grant / award (derivative) | 2,360 | $0.00 | 2,360 |
| 2024-05-03 | Grant / award | 750 | $0.00 | 750 |
| 2023-06-30 | Grant / award | 699 | $100.23 | 15,697 |
| 2023-04-28 | Grant / award (derivative) | 2,880 | $0.00 | 2,880 |
| 2023-04-28 | Grant / award | 820 | $0.00 | 820 |
| 2022-06-30 | Grant / award | 648 | $92.66 | 14,998 |
| 2022-06-13 | Grant / award (derivative) | 6,400 | $0.00 | 6,400 |
| 2021-06-30 | Grant / award | 1,409 | $85.22 | 14,350 |
| 2021-06-14 | Grant / award (derivative) | 7,850 | $0.00 | 7,850 |
| 2020-08-04 | Option exercise (derivative) | 14,660 | $0.00 | 0 |
| 2020-08-04 | Option exercise | 14,660 | $41.92 | 27,601 |
| 2020-08-04 | Open-market sale | 14,660 | $95.58 | 12,941 |
| 2020-06-30 | Grant / award | 1,553 | $77.30 | 12,941 |
| 2020-06-15 | Grant / award (derivative) | 10,950 | $0.00 | 10,950 |
| 2019-11-05 | Open-market buy | 300 | $67.19 | 11,388 |
| 2019-06-28 | Grant / award | 753 | $73.06 | 11,088 |
| 2019-06-17 | Grant / award (derivative) | 8,600 | $0.00 | 8,600 |
| 2018-11-06 | Option exercise (derivative) | 15,762 | $0.00 | 0 |
| 2018-11-06 | Option exercise | 15,762 | $34.04 | 26,097 |
| 2018-11-06 | Open-market sale | 15,762 | $66.54 | 10,335 |
| 2018-06-29 | Grant / award | 2,070 | $53.16 | 10,335 |
| 2018-06-18 | Grant / award (derivative) | 13,200 | $0.00 | 13,200 |
| 2017-06-30 | Grant / award | 2,121 | $51.88 | 8,265 |
| 2017-06-19 | Grant / award (derivative) | 11,590 | $0.00 | 11,590 |
| 2016-06-30 | Grant / award | 972 | $102.89 | 3,072 |
| 2016-06-20 | Grant / award (derivative) | 6,479 | $0.00 | 6,479 |
| 2016-06-20 | Grant / award (derivative) | 6,480 | $0.00 | 6,480 |
| 2015-09-02 | Open-market buy | 1,000 | $84.82 | 2,100 |
| 2015-06-30 | Grant / award | 617 | $81.13 | 1,100 |
| 2015-06-22 | Grant / award (derivative) | 7,330 | $0.00 | 7,330 |
| 2014-06-30 | Grant / award | 483 | $69.95 | 483 |
| 2014-05-01 | Grant / award (derivative) | 7,881 | $0.00 | 7,881 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.